Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Anti-inflammatory agents and cerebral vasospasm.

D Chyatte1

  • 1Section of Neurosurgery, Yale University School of Medicine, New Haven, Connecticut.

Neurosurgery Clinics of North America
|April 1, 1990
PubMed
Summary

Delayed cerebral ischemia from vasospasm is a major risk after aneurysmal subarachnoid hemorrhage. Anti-inflammatory drugs show promise but require safer development to manage this serious complication.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Functional outcome after repair of unruptured intracranial aneurysms.

Journal of neurosurgery·2001
Same author

Nuances of middle cerebral artery aneurysm microsurgery.

Neurosurgery·2001
Same author

Recommendations for the management of patients with unruptured intracranial aneurysms: A Statement for healthcare professionals from the Stroke Council of the American Heart Association.

Stroke·2000
Same author

Recommendations for the management of patients with unruptured intracranial aneurysms: A statement for healthcare professionals from the Stroke Council of the American Heart Association.

Circulation·2000
Same author

Inflammation and intracranial aneurysms.

Neurosurgery·1999
Same author

Detachable balloon embolization: concomitant use of a second safety balloon.

AJNR. American journal of neuroradiology·1999

Area of Science:

  • Neurology
  • Inflammation Research
  • Pharmacology

Background:

  • Delayed cerebral ischemia, caused by vasospasm, is a leading cause of death and disability in survivors of aneurysmal subarachnoid hemorrhage.
  • The exact causes of vasospasm are unknown, but the inflammatory response post-subarachnoid hemorrhage is increasingly implicated.
  • Current treatments are limited by concerns over serious side effects.

Purpose of the Study:

  • To explore the potential of anti-inflammatory agents in managing vasospasm after subarachnoid hemorrhage.
  • To highlight the link between inflammation and vasospasm.
  • To discuss the need for safer anti-inflammatory drug development.

Main Methods:

  • Review of existing animal and preliminary clinical studies on anti-inflammatory agents.
  • Analysis of the role of inflammatory responses in vasospasm.
  • Discussion of the limitations and future directions for therapeutic interventions.

Main Results:

  • Both steroidal and nonsteroidal anti-inflammatory agents may offer benefits in preventing or treating vasospasm.
  • Concerns regarding side effects have restricted the clinical application of current anti-inflammatory therapies.
  • Further research into the biological mechanisms of vasospasm is needed.

Conclusions:

  • Anti-inflammatory strategies hold potential for treating vasospasm following subarachnoid hemorrhage.
  • Development of safer and more effective anti-inflammatory drugs is crucial.
  • Understanding the biology of vasospasm will guide the design of future therapies.

Related Experiment Videos